Medical Condition News

RSS

Tel Aviv University investigates cause and effects of SCA syndrome

Sudden Cardiac Arrest syndrome (SCA) is poorly understood, but it's a real danger for the otherwise young and healthy. For no apparent reason, the heart suddenly stops beating, and without treatment death may follow within minutes. It's why some athletes drop dead on the track and why a young man, without any warning, suddenly dies while sitting at his desk.

11 Mar 2010

Age-related macular degeneration affects central vision in older Americans

Indianapolis resident Harry Traugott was an active retiree, participating in community events, driving and even teaching English as a second language at two community centers. He’d been diagnosed with age-related macular degeneration (AMD), but the disease had not caused significant vision loss. It wasn’t until he had trouble seeing while driving, watching television

11 Mar 2010

FDA provides guidance on Restanza clinical program in treatment of CABP

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.

11 Mar 2010

Smith & Nephew launches TWINFIX Ultra PK Suture Anchor for rotator cuff repair

Smith & Nephew's Endoscopy Division today announced the introduction of the TWINFIX™ Ultra PK Suture Anchor, a new anchor to address wide variation in bone density and tissue quality for rotator cuff repair in the shoulder. The device is currently being featured at Smith & Nephew Endoscopy's booth at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in New Orleans.

11 Mar 2010

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

BioSante Pharmaceuticals, Inc. today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec (imatinib mesylate).

11 Mar 2010

National Public Health Agenda for Osteoarthritis launched with assistance from UNC

Betty Isaacs of Boone, N.C., knows all about the chronic pain of osteoarthritis and the impact it has on her life. "The pain in my knee was so bad, I would just sit around," Isaacs said.

11 Mar 2010

Survey: Acute migraine therapy would earn 45% patient share in treatment of migraine

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that an acute migraine therapy that is not contraindicated in patients with a history, symptoms or signs of vascular disease and also offers improved efficacy and fast-acting oral delivery would earn a 45 percent patient share in the treatment of migraine, according to surveyed U.S. neurologists.

11 Mar 2010

ADI’s 20-bit DAC enables superior image clarity, resolution, and contrast in medical imaging systems

MRI (magnetic resonance imaging) scans provide extraordinarily clear images of the human body and are commonly used to diagnose a wide range of illnesses and injuries, such as Alzheimer’s disease, cancerous tumors, and torn ligaments. Analog Devices, Inc., the leading provider of data conversion technology and longtime collaborator with the medical imaging industry, today introduced a breakthrough in data conversion that gives clinicians and radiologists the superior image clarity they need to see smaller anatomical structures and abnormalities, such as breast cancer cells, than ever before.

11 Mar 2010

Data from novel Hedgehog pathway inhibitor program to be presented at upcoming conferences

Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that members of its senior leadership and scientific teams will be leading discussions and presenting data from its novel Hedgehog pathway inhibitor program – an emerging area of cancer research – at several upcoming conferences.

11 Mar 2010

Refining treatments to target only key heart-related mechanisms may improve effectiveness

Current drugs used to treat heart failure and arrhythmias (irregular heartbeat) have limited effectiveness and have side effects. New basic science findings from a University of Iowa study suggest a way that treatments could potentially be refined so that they work better and target only key heart-related mechanisms.

11 Mar 2010

Platelet dosage can be lowered in transfusions for cancer and bone-marrow transplant patients

Physicians may be able to safely lower the platelet dosage in transfusions for cancer and bone-marrow transplant patients without risking increased bleeding, according to new research involving UT Southwestern Medical Center and 28 other medical institutions.

11 Mar 2010

Study uncovers mechanism facilitating motivation for alcohol after extended abstinence

New research provides exciting insight into the molecular mechanisms associated with addiction and relapse. The study, published by Cell Press in the March 11 issue of the journal Neuron, uncovers a crucial mechanism that facilitates motivation for alcohol after extended abstinence and opens new avenues for potential therapeutic intervention.

11 Mar 2010

New Maryland legislation protects minors from cancer risks caused by UV-radiation of indoor tanning

New Maryland legislation to protect youth from melanoma, the deadliest form of skin cancer, is based on significant scientific evidence that indoor tanning before the age of 30 is undeniably linked to increased risk of developing the disease. Senator James N. Robey and Delegate William A. Bronrott represent a broad-based coalition of 20 legislators in the Senate and House co-sponsoring cross-filed bills SB 718 and HB 1039 to prohibit minors' use of tanning devices in tanning facilities and prevent any marketing offers of these services to minors.

11 Mar 2010

Non-smoked medical cannabis products needed, says National Drug Control Policy Deputy Director

Cannabis Science, Inc., a pioneering US pharmaceutical cannabis company, notes that comments by President Obama's Deputy Director of the White House Office of National Drug Control Policy, Tom McClellan, in yesterday's USA TODAY pinpoints the need for non-smoked medical cannabis products similar to those currently being developed for FDA clinical trials by Cannabis Science.

11 Mar 2010

2010 AAOS conference highlights ways to prevent orthopaedic traumas in children

Over the years, all terrain vehicles (ATVs) and motocross motorcycles have gained popularity and marketed as toys to consumers. These high-velocity machines can weigh between 300 and 600 pounds, and run on average between 25 and 60 miles per hour, while some even reach maximum speeds of 75 miles per hour.

11 Mar 2010

Advitech receives product licence for psoriasis treatment product

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announces today that the Natural Health Products Directorate (NHPD) has issued to Advitech, on March 8, 2010, a Natural Product Number (NPN) for one of its main products, XP-828L/Dermylex.

11 Mar 2010

Evotec completes first-in-human Phase I study of EVT 103 for treatment-resistant depression

Evotec AG today announced two positive aspects that strengthen its integrated product development in treatment-resistant depression in its strategic alliance with Roche.

11 Mar 2010

Sleep deprivation may increase heart attack risk

On average, people go to work or school on the first Monday of Daylight Savings after sleeping 40 fewer minutes than normal. And recent studies have found there's a higher risk of heart attacks, traffic accidents and workplace injuries on the first Monday of Daylight Savings.

11 Mar 2010

Following existing cholesterol-lowering target guidelines can prevent more heart disease-related incidents

Only half of all patients at high risk of heart disease are given correct targets for lowering their cholesterol levels according to a study of 25,250 patients in Germany published online today (Thursday 11 March) in the European Heart Journal.

11 Mar 2010

Controlling cholesterol using biologically active molecules isolated from algal infusion

Researchers at Wayne State University's Department of Nutrition and Food Science believe they've uncovered a unique method to control and regulate cholesterol using biologically active molecules isolated from ProAlgaZyme™ -- a proprietary algal infusion produced by Health Enhancement Products, Inc., of Scottsdale, Arizona.

11 Mar 2010

Medical Condition News

Tel Aviv University investigates cause and effects of SCA syndrome

Age-related macular degeneration affects central vision in older Americans

FDA provides guidance on Restanza clinical program in treatment of CABP

Smith & Nephew launches TWINFIX Ultra PK Suture Anchor for rotator cuff repair

Positive results from BioSante Pharmaceuticals' GVAX Leukemia vaccine human clinical study

National Public Health Agenda for Osteoarthritis launched with assistance from UNC

Survey: Acute migraine therapy would earn 45% patient share in treatment of migraine

ADI’s 20-bit DAC enables superior image clarity, resolution, and contrast in medical imaging systems

Data from novel Hedgehog pathway inhibitor program to be presented at upcoming conferences

Refining treatments to target only key heart-related mechanisms may improve effectiveness

Platelet dosage can be lowered in transfusions for cancer and bone-marrow transplant patients

Study uncovers mechanism facilitating motivation for alcohol after extended abstinence

New Maryland legislation protects minors from cancer risks caused by UV-radiation of indoor tanning

Non-smoked medical cannabis products needed, says National Drug Control Policy Deputy Director

2010 AAOS conference highlights ways to prevent orthopaedic traumas in children

Advitech receives product licence for psoriasis treatment product

Evotec completes first-in-human Phase I study of EVT 103 for treatment-resistant depression

Sleep deprivation may increase heart attack risk

Following existing cholesterol-lowering target guidelines can prevent more heart disease-related incidents

Controlling cholesterol using biologically active molecules isolated from algal infusion

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News